Stock Information
Nurix Therapeutics Inc (NRIX)
Ticker Symbol: NRIX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,192.46 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.16
Revenue (TTM): $0.65 M
Dividend Yield: N/A%
ROE: -64.21%
Latest News
-
HC Wainwright & Co. Reiterates Buy on Nurix Therapeutics, Maintains $32 Price Target
Fri, Apr 10, 2026 7:21 AM
-
Nurix: 'Strong Buy' Bexobruditeg Development And Dual Degrader Zelebrudomide
Thu, Apr 9, 2026 3:49 PM
-
Wells Fargo Maintains Overweight on Nurix Therapeutics, Lowers Price Target to $28
Thu, Apr 9, 2026 10:49 AM
-
Needham Reiterates Buy on Nurix Therapeutics, Maintains $26 Price Target
Wed, Apr 8, 2026 1:18 PM
-
Nurix Therapeutics Q1 EPS $(0.79) Beats $(0.86) Estimate, Sales $6.252M Miss $16.607M Estimate
Wed, Apr 8, 2026 8:42 AM
-
Earnings Scheduled For April 8, 2026
Wed, Apr 8, 2026 7:11 AM
Key Financials
Financial data not available
